MoneyWorks4Me

Ind-Swift Laboratories informs about updates

01 Jun 2023 Evaluate
Pursuant to Regulation 57 (1) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Ind-Swift Laboratories has informed that the Company has made the payment of monthly interest for the month of May, 2023 to the Investors of Non-Convertible Debentures (NCDs) ISIN-INE915B07024, on 31st May, 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..